<DOC>
	<DOCNO>NCT02880033</DOCNO>
	<brief_summary>Peripheral blood mononuclear cell ( PBMC ) platelet could interest ex vivo model study brain disease . Indeed , access neuron patient . However , PBMC exhibit different physiopathological mechanism ubiquitous ( i.e . oxidative stress , mitochondriopathy energy metabolism , inflammation , protein folding , iron metabolism program cell death ... ) . The platelet pivotal heal system large range growth factor . A new therapeutic concept conservative iron chelation deferiprone neuroprotection development . The action deferiprone different mechanism notably oxidative stress obtain collection PBMC platelets patient Parkinson 's disease Amyotrophic lateral sclerosis healthy control study ex vivo . PBMC platelet store future analysis .</brief_summary>
	<brief_title>Oxidative Stress Apoptosis Energy Metabolism Deferiprone From Circulating Lymphocytes</brief_title>
	<detailed_description>The study collection PBMC platelets 30 patient Parkinson 's disease 30 patient Amyotrophic lateral sclerosis 30 healthy control . The collection perform either cytapheresis half patient collect whole blood half . PBMC platelet store minus 80Â°C . PBMC patient control expose ex vivo different pathological condition ( mainly Hydrogen peroxide , menadione , hypoxia ... ) without deferiprone analyse whether level oxidative stress ( Reactive Oxygen Species notably hydroxyl radical hydroxypethidine probe flow cytometry ) reduce deferiprone ( primary criterion . Secondary analysis concern level iron , energy metabolism ( aerobic versus anaerobic level Adenosine triphosphate production ) , type cell death ( apoptosis , autophagy new program cell death : Ferroptosis ) inflammation . Finally , level growth factor effectiveness study platelet .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<criteria>Parkinson 's disease accord Movement Disorders Society criterion Amyotrophic Lateral Sclerosis accord El escorial criterion Age sex match healthy control Severe comorbidities ( cancer , degenerative disease , hemopathy , inflammatory disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Amyotrophic lateral sclerosis</keyword>
	<keyword>Peripheral blood mononuclear cell</keyword>
	<keyword>ex vivo model oxidative stress</keyword>
	<keyword>iron metabolism chelation</keyword>
</DOC>